Acute Ischemic Stroke Care: Reperfusion Window Updates
Acute ischemic stroke represents a critical medical emergency requiring urgent revascularization. Therefore, timely acute ischemic stroke treatment remains essential to prevent irreversible neuronal death and severe disability. Consequently, clinicians must act rapidly when patients present with focal neurologic deficits.
Recognizing Stroke Presentation and Initial Workup
Cerebral artery occlusion triggers sudden neurologic impairment. For example, common presentations include facial drooping, unilateral arm weakness, and severe aphasia. Furthermore, patients may experience sudden ataxia or visual loss. Emergency teams must transport suspected patients immediately to an appropriate stroke center. Subsequently, clinicians must perform noncontrast computed tomography without delay to rule out intracranial hemorrhage.
Intravenous Thrombolysis in Acute Ischemic Stroke Treatment
Intravenous thrombolysis serves as the primary medical therapy for disabling deficits within 4.5 hours of onset. Specifically, updated guidelines recommend either tenecteplase or alteplase for eligible candidates. Tenecteplase provides practical advantages because clinicians administer it as a rapid single bolus. Moreover, pooled randomized trials demonstrate a 10% absolute increase in good functional outcomes with thrombolysis. In addition, advanced neuroimaging can extend the thrombolytic window up to 9 hours when salvageable brain tissue exists. Thrombolysis can even extend up to 24 hours in selected large vessel occlusions when thrombectomy remains unavailable.
Mechanical Thrombectomy for Large Vessel Occlusion
Endovascular thrombectomy provides dramatic clinical benefits for patients with large vessel occlusions. Indeed, guidelines deliver a Class 1 recommendation for thrombectomy within 6 hours of symptom onset. Furthermore, eligible patients can safely undergo catheter thrombectomy up to 24 hours after last known normal. Clinicians should administer intravenous thrombolysis first unless contraindications exist. Importantly, endovascular therapy yields an absolute 20% increase in functional independence compared with medical therapy alone. Therefore, stroke care networks must expedite direct patient triage to endovascular centers, which is a vital competency covered in a comprehensive Certification Course In Stroke Medicine.
Frequently Asked Questions
Q1: What is the recommended time window for intravenous thrombolysis?
The standard window is within 4.5 hours of symptom onset. However, perfusion imaging can extend this window up to 9 hours in salvageable tissue. Furthermore, selected patients without thrombectomy access can receive thrombolysis up to 24 hours.
Q2: Why is tenecteplase favored over alteplase in recent protocols?
Tenecteplase offers equal clinical efficacy and noninferiority. Additionally, clinicians administer tenecteplase as a rapid single bolus, which significantly streamlines emergency workflows and patient transfers.
Q3: How much functional benefit does mechanical thrombectomy provide?
Mechanical thrombectomy produces an absolute 20% increase in functional independence compared to medical management alone.
References
- Albers GW et al. Treatment of Acute Ischemic Stroke: A Review. JAMA. 2026 Nov 12. doi: 10.1001/jama.2026.19482. PMID: 43018963.
- American Heart Association/American Stroke Association. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2026;57(3):e1-e65.
- Yoo AJ et al. One-Year Outcomes After Endovascular Treatment for Large Acute Ischemic Stroke. JAMA. 2026;336(5):450-459.
